Početna › Bolesti pluća › Missouri
Kliničke studije za Bolesti pluća u državi Missouri
8 studija za Bolesti pluća traži sudionike na lokacijama u državi Missouri.
Gradovi u državi Missouri
Službeni tekst studije (engleski)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Kansas City
- Research Site, St Louis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT05624450Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Washington University Center for Advanced Medicine, St Louis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06765109A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Washington University School of Medicine, St Louis
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT06977581A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, St Louis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06572384A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Oncology Hematology Associates, Springfield
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06119581A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Columbia
U tijeku regrutacijaFaza 2
Od 4 do 11 godina · Oba spola · Ažurirano 27. kol 2026. · NCT07525375A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Washington University Infusion Center Pharmacy, St Louis
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 27. svi 2026. · NCT03093116A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Washington University School of Medicine - Siteman Cancer Center, St Louis
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 15. pro 2025. · NCT06619561Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.